Five details:
1. Verily’s parent company, Alphabet, served as a leader of the financing round as well as other investors, including Silver Lake and Temasek, according to a news release emailed to Becker’s.
2. The financing will support Verily’s expansion of its commercial businesses, including its clinical research platform Baseline and Verily Health Platforms, which offers population health, clinical care delivery and chronic disease management services.
3. Since the start of the pandemic, Verily’s Baseline platform has provided COVID-19 testing and research and with partner organizations has screened and tested nearly 2 million people at 351 testing sites.
4. Verily Health Platforms launched its Healthy at Work program this year to help businesses and universities reopen safely during the pandemic with digital tools to screen people for COVID-19 and to conduct contact tracing.
5. Verily will also use the funding to advance its life sciences programs in surgery, pathology and immunology.
More articles on digital transformation:
Highmark, Google Cloud sign 6-year partnership deal: 5 details
Johns Hopkins creates COVID-19 death risk calculator
22 digital health startups that raised over $50M in 2020
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
